Archived documents

Documents past their public comment period for Healthcare & Public Health.

FDAOther

PSG_219389 - Draft Guidance on Mirdametinib

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_212801 - Draft Guidance on Osilodrostat Phosphate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_216490 - Draft Guidance on Palopegteriparatide

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_205739 - Draft Guidance on Patiromer Sorbitex Calcium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_019887 - Draft Guidance on Pentamidine Isethionate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_019561 - Draft Guidance on Potassium Chloride

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_006460 - Draft Guidance on Protamine Sulfate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_219108 - Draft Guidance on Rocuronium Bromide

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_020658 - Draft Guidance on Ropinirole Hydrochloride

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_022008 - Draft Guidance on Ropinirole Hydrochloride

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_219943 - Draft Guidance on Selumetinib Sulfate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_206406 - Draft Guidance on Tacrolimus

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22